CrushSCI.com
124.6Average days
107.5Median days
18Fastest days
257Longest days
342025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

111 days

Clarithromycin Use in the First Trimester Is Not Associated With Fetal Abnormalities

Authors
Tomo Suzuki; Mikako Goto; Tatsuhiko Anzai; Ritsuko Yamane; Omi Watanabe; Kunihiko Takahashi; Atsuko MurashimaShow moreShow less
Affiliations
1. Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health National Center for Child Health and Development Tokyo Japan; 2. Division of Obstetrics Center for Maternal‐Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development Tokyo Japan; 3. Department of Biostatistics M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo Tokyo Japan; 4. Department of Pharmacy Toranomon Hospital Tokyo Japan; 5. Department of Rheumatology and Applied Immunology Saitama Medical University Moroyama JapanShow moreShow less
Source PDF DOI Publisher page
107 days

A Novel MAF Variant Causing Aymé‐Gripp Syndrome With Transient Anemia

Authors
Masateru Hara; Takeshi Morisawa; Daiichiro Hasegawa; Kandai Nozu; Naoya MorisadaShow moreShow less
Affiliations
1. Department of Clinical Genetics Hyogo Prefectural Kobe Children's Hospital Kobe Japan; 2. Department of Pediatrics Kakogawa Central Hospital Kakogawa Japan; 3. Department of Hematology Hyogo Prefectural Kobe Children's Hospital Kobe Japan; 4. Department of Pediatrics Kobe University Graduate School of Medicine Kobe JapanShow moreShow less
Source PDF DOI Publisher page
191 days

Worldwide Burden of Urogenital Congenital Anomalies Across Childhood and Adolescence, 1990–2021: Results From the Global Burden of Disease Study 2021

Authors
Jie Luo; Xi LuoShow moreShow less
Affiliations
1. Good Clinical Practice Center Guizhou Provincial People's Hospital Guiyang China; 2. Department of Pediatric Surgery The Affiliated Hospital of Guizhou Medical University Guiyang China; 3. School of Clinical Medicine Guizhou Medical University Guiyang China; 4. Faculty of Medical and Health Sciences University of Auckland Auckland New ZealandShow moreShow less
Source PDF DOI Publisher page
145 days

Clinical Outcomes of Twin Reversed Arterial Perfusion ( TRAP ) Sequence: A Retrospective Analysis From a Tertiary Center

Authors
Fikriye Karanfil Yaman; Huriye Ezveci; Şükran Doğru; Melike Sevde Harmancı; Ali AcarShow moreShow less
Affiliations
1. Division of Maternal and Fetal Medicine, Faculty of Medicine Necmettin Erbakan University (NEU) Konya Turkey; 2. Division of Maternal and Fetal Medicine Konya City Hospital Konya TurkeyShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.